CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that it has been named to FierceBiotech’s 7th annual “Fierce 15” list, designating it as one of the top 15 emerging companies in biotechnology.
